Rock Springs Capital Management LP Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$2.6B
Holdings
147
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (147 positions)
| Stock | Value |
|---|---|
KURAKURA ONCOLOGY INC | $7.3M |
—BLUEBIRD BIO INC | $7.1M |
ZLABZAI LAB LTD | $7.0M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $6.9M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $6.8M |
—MYOVANT SCIENCES LTD | $6.7M |
RYTMRHYTHM PHARMACEUTICALS INC | $6.7M |
—ACHILLION PHARMACEUTICALS IN | $6.7M |
—LA JOLLA PHARMACEUTICAL CO | $6.5M |
CRVSCORVUS PHARMACEUTICALS INC | $6.3M |
MGNXMACROGENICS INC | $5.7M |
BSXBOSTON SCIENTIFIC CORP | $5.6M |
INSM 1.75 01/15/25INSMED INC | $5.5M |
—DERMIRA INC | $5.5M |
—GTX INC DEL | $5.4M |
—ALDER BIOPHARMACEUTICALS INC | $5.2M |
—MEDICINES CO | $5.1M |
—ENVISION HEALTHCARE CORP | $4.9M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $4.8M |
—PARATEK PHARMACEUTICALS INC | $4.6M |
—CLEMENTIA PHARMACEUTICALS IN | $4.5M |
—CORREVIO PHARMA CORP | $4.5M |
NVAXNOVAVAX INC | $4.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $4.1M |
—MEDICINES CO | $3.7M |
CGENCOMPUGEN LTD | $3.6M |
SLDBSOLID BIOSCIENCES INC | $3.4M |
ITCIEURINTRA CELLULAR THERAPIES INC | $3.3M |
—ALLERGAN PLC | $2.9M |
—EGALET CORP | $2.8M |
—MENLO THERAPEUTICS INC | $2.7M |
—RESTORBIO INC | $2.5M |
—NABRIVA THERAPEUTICS PLC | $2.2M |
MCRB1EURSERES THERAPEUTICS INC | $1.9M |
KNSAKINIKSA PHARMACEUTICALS LTD | $1.6M |
—CIDARA THERAPEUTICS INC | $1.6M |
—THERAVANCE BIOPHARMA INC | $1.5M |
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | $1.4M |
BCRXBIOCRYST PHARMACEUTICALS | $1.4M |
—RADIUS HEALTH INC | $1.4M |
SCYXEURSCYNEXIS INC | $1.3M |
—PROTEOSTASIS THERAPEUTICS IN | $1.3M |
PRTAPROTHENA CORP PLC | $1.2M |
—PACIRA PHARMACEUTICALS INC | $932K |
—DERMIRA INC | $827K |
—CHIASMA INC | $788K |
MCKMCKESSON CORP | $667K |
PreviousPage 2 of 2